- NYSE:KODK rises 5.24% after a renowned investment firm initiates a new position.
- Investors anticipate the federal loan being released and Kodak to begin supplying the U.S. with active pharmaceutical ingredients.
It has been a strange year for a multitude of reasons but not the least of which has been the sudden resurgence of Eastman Kodak (NYSE:KODK) as a stock to invest in again. Kodak made headlines after receiving a $765 million government loan from the Trump Administration in July to jumpstart domestic production of active pharmaceutical ingredients – some that were being planned to use in a potential coronavirus vaccine. Kodak shares spiked over 3000% on the news of the loan and the once-dormant photography stock was making headlines all over the investing world.
Since that surge, the stock has come back down to Earth falling over 90% since it reached its 52-week high of $60. News of insider training and dishonest executive decisions soured investors – especially after the loan was paused based on an SEC investigation into the company. Recently, renowned investor David Shaw of D.E. Shaw & Company has initiated a position in Kodak, giving investors the impression that shares may have reached their bottom. While trading at only 0.36x sales and with cash reserves equal to $2.83 per share – Shaw may have seen this as too cheap of an opportunity to pass up given the current climate.
KODK stock news
Even with Shaw’s investment, it is difficult to remain excited about shares of Kodak as inept ownership making bad decisions should always be a red flag to investors. There is an ongoing push from the Trump Administration to return pharmaceutical manufacturing back to US soil so as not to rely so heavily on China. The Federal election in November could have an effect on this sentiment and while shares of KODK could rise – they could just as easily return to obscurity.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD holds lower ground below 0.6300 despite renewed China optimism
AUD/USD stays depressed below the 0.6300 mark in the Asian session on Thursday amid uncertainty over US President Donald Trump's tariff plans. The Aussie shrugs off a risk-rally in Chinese stocks on fresh support measures as the US Dollar holds ground ahead of top-tier US data releases.
USD/JPY bounces to near 155.50 amid modest US Dollar uptick
USD/JPY finds fresh buyers and bounces to near 155.50 in the Asian session on Thursday. The pair reverses an early dip-=led by the better-than-expected Japanese Trade Balance data. Further upside could be capped amid prospects for an imminent BoJ rate hike on Friday.
Gold buyers pause but refuse to give up yet
Gold price consolidates its three-day bullish momentum early Thursday, having reached three-month highs of $2,763 on Wednesday. Gold buyers take a breather as attention turns toward US fundamentals, with the weekly Jobless Claims on tap.
Ripple's XRP ETFs: Is SEC approval on the horizon following CME's rumored futures launch?
The Chicago Mercantile Exchange allegedly plans to launch Ripple's XRP and Solana futures contracts following a now-deleted post on a staging website detailing how trading for both assets will function.
Netflix posts record quarter, as Trump talks tariffs on China
There has been a positive tone to risk this week, as the market digests Trump 2.0. However, Trump is not the only show in town. Earnings reports are also a key driver of stock indices, and the news is good.
Trusted Broker Reviews for Smarter Trading
VERIFIED Discover in-depth reviews of reliable brokers. Compare features like spreads, leverage, and platforms. Find the perfect fit for your trading style, from CFDs to Forex pairs like EUR/USD and Gold.